CEPI (Coalition for Epidemic Preparedness Innovations) · 19 hours ago
Director, R&D Executive Director’s Office (EDO)
CEPI (Coalition for Epidemic Preparedness Innovations) is an international coalition focused on accelerating the development of vaccines and biologic countermeasures against epidemic threats. The Director of the R&D Executive Director’s Office will lead strategic initiatives, oversee daily operations, and ensure alignment within the R&D division to effectively deliver on CEPI's objectives.
Research
Responsibilities
Lead strategic initiatives from development through successful execution, working closely with the Executive Director of R&D and the R&D leadership team
Effectively prioritize activities including balancing different perspectives to ensure R&D leadership remains focused on critical objectives, milestones and deliverables
Oversee daily operations within the division, including: providing support to the Executive Director and coordination of R&D leadership team; execution of CEPI’s technical governance; delivery of successful external R&D events and provision of departmental administrative support, through collaboration with R&D leaders, other technical and non-technical divisions/departments, and external stakeholders and partners
Ensure effective development and integration of R&D strategy into CEPI’s strategy and work closely with the Executive Director of R&D and all internal stakeholders to prepare the R&D division’s strategy, structure and processes for CEPI 3.0
Identify areas of improvement in current R&D division and cross-divisional processes and make actionable recommendations for optimized efficiency and productivity. Working closely with R&D leaders and People and Organisation to set the direction for organizational development in R&D and ensure effective communication of change initiatives
Represent the Executive Director of R&D in internal and external meetings as appropriate
Maintain and build networks and support the Executive Director of R&D’s high quality working relationships with a wide range of colleagues internally and externally; support development of CEPI’s overall stakeholder management approach
Lead the multifunctional R&D Executive Director’s Office team to execute the Division’s operational goals for internal governance, strategic planning and analytics, effective partnerships, and delivery of R&D events
Qualification
Required
Masters or further advanced degree (PhD desirable) in relevant field, with an understanding of end-to-end vaccine development
Extensive experience in life sciences field, including in technical, strategic, policy or funding roles related to vaccine development
Strong leadership skills, with the ability to build trust with partners and to work collaboratively with colleagues from a wide range of disciplines and backgrounds
Excellent ability to think critically, strategise and persuade key stakeholders to resolve differences in an effective manner
Ability to make decisions in a fast paced and changing environment that balance different equities and produce the best possible results for the R&D division and for the organisation
Proven experience leading multi-functional teams
Strong program management and strategic capabilities
Ability to build complex cross-group/department plans, drive, track and report execution progress
Strong communication skills, verbal and written, including presentation skills
Strong analytical skills
Ability to manage confidential issues with complete discretion
Preferred
Experience working with international partners and health organisations is desirable
Benefits
The opportunity to work together with leading experts on solutions for global challenges
Experience in the international effort on developing vaccines against emerging infectious diseases and accelerating vaccine development response to outbreaks
A diverse and inclusive working environment
Company
CEPI (Coalition for Epidemic Preparedness Innovations)
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need.
Funding
Current Stage
Growth StageRecent News
2026-01-12
2025-12-19
2025-12-18
Company data provided by crunchbase